Old Web
English
Sign In
Acemap
>
authorDetail
>
Aida Raventós
Aida Raventós
Pharmacology
Emicizumab
Thrombin
Blood Coagulation Factor Inhibitors
Medicine
4
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combination of emicizumab and factor VIII has no additive effects after reaching normal coagulation levels
2021
Journal of Thrombosis and Haemostasis
Maria‐Isabel Bravo
Aida Raventós
Alba Pérez
Montserrat Costa
Todd Willis
Show All
Source
Cite
Save
Citations (0)
Ex Vivo Evaluation of the Effect of Plasma-Derived Factor VIII/Von Willebrand Factor in Patients with Severe Hemophilia_A on Prophylaxis with Emicizumab By Thrombin Generation Assay
2021
Blood
María Isabel Bravo
Aida Raventós
Alba Pérez
Elena G. Arias Salgado
María Teresa Álvarez-Román
Nora Butta
Victor Jiménez Yuste
Montserrat Costa
Todd Willis
Show All
Source
Cite
Save
Citations (0)
Non-additive effect on thrombin generation when a plasma-derived factor VIII/ von Willebrand factor (FVIII/VWF) is combined with emicizumab in vitro.
2020
Journal of Thrombosis and Haemostasis
Maria‐Isabel Bravo
Aida Raventós
Alba Pérez
Montserrat Costa
Todd Willis
Show All
Source
Cite
Save
Citations (4)
Short-Fiber Protein of Ad40 Confers Enteric Tropism and Protection Against Acidic Gastrointestinal Conditions
2013
Human Gene Therapy Methods
Ester Rodríguez
Carolina Romero
Adolfo Rio
Marta Miralles
Aida Raventós
Laura Planells
Joan F. Burgueño
Hirofumi Hamada
Jose C. Perales
Assumpció Bosch
M.A. Gassull
Ester Fernández
Miguel Chillón
Show All
Source
Cite
Save
Citations (14)
1